<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39333655</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>RNA-Seq analysis of human heart tissue reveals SARS-CoV-2 infection and inappropriate activation of the TNF-NF-κB pathway in cardiomyocytes.</ArticleTitle><Pagination><StartPage>22044</StartPage><MedlinePgn>22044</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22044</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-69635-6</ELocationID><Abstract><AbstractText>The negative impact of SARS-CoV-2 virus infection on cardiovascular disease (CVD) patients is well established. This research article explores the cellular pathways involved in underlying heart diseases after infection. The systemic inflammatory response to SARS-CoV-2 infection likely exacerbates this increased cardiovascular risk; however, whether the virus directly infects cardiomyocytes remains unknown due to limited multi-omics data. While public transcriptome data exists for COVID-19 infection in different cell types (including cardiomyocytes), infection times vary between studies. We used available RNA-seq data from human heart tissue to delineate SARS-CoV-2 infection and heart failure aetiology specific gene expression signatures. A total of fifty-four samples from four studies were analysed. Our aim was to investigate specific transcriptome changes occurring in cardiac tissue with SARS-CoV-2 infection compared to non-infected controls. Our data establish that SARS-CoV-2 infects cardiomyocytes by the TNF-NF-κB pathway, potentially triggering acute cardiovascular complications and increasing the long-term cardiovascular risk in COVID-19 patients.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dave</LastName><ForeName>Kirtan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat, 391760, India. kirtandave11@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Laboratory, Research &amp; Development Cell, Parul University, Vadodara, Gujarat, 391760, India. kirtandave11@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jain</LastName><ForeName>Mukul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat, 391760, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cell &amp; Developmental Biology Lab, Research &amp; Development Cell, Parul University, Vadodara, Gujarat, 391760, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ranchi University, Ranchi, 834001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delta</LastName><ForeName>Anil Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ranchi University, Ranchi, 834001, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kole</LastName><ForeName>Chittaranjan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Neotia University, Sarisha, 743368, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaushik</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chaudhary Charan Singh Haryana Agricultural University, Hisar, 125004, India. prakau@hau.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="Y">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="Y">RNA-Seq</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="Y">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bioinformatics</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiomyocytes</Keyword><Keyword MajorTopicYN="N">Gene</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">RNA-seq</Keyword><Keyword MajorTopicYN="N">TNF-NF-κB</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333655</ArticleId><ArticleId IdType="pmc">PMC11437285</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-69635-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-69635-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Infectious Disease Subdivision Leadership. The Journal of molecular diagnostics : JMD. 2020;22(8):968-74. 10.1016/j.jmoldx.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303040</ArticleId><ArticleId IdType="pubmed">32565306</ArticleId></ArticleIdList></Reference><Reference><Citation>Afewerky, H. K. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Exp. Biol. Med. (Maywood)245(15), 1299–1307. 10.1177/1535370220942126 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7441345</ArticleId><ArticleId IdType="pubmed">32635753</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, D. A. &amp; Levitan, D. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infecting pregnant women and the fetus, intrauterine transmission, and placental pathology during the coronavirus disease 2019 (COVID-19) pandemic: It’s complicated. Arch. Pathol. Lab. Med.145(8), 925–928. 10.5858/arpa.2021-0164-ED (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33878167</ArticleId></ArticleIdList></Reference><Reference><Citation>Vosko, I., Zirlik, A. &amp; Bugger, H. Impact of COVID-19 on cardiovascular disease. Viruses10.3390/v15020508 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9962056</ArticleId><ArticleId IdType="pubmed">36851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J. &amp; Prescott, H. C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA324(8), 782–793. 10.1001/jama.2020.12839 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi, J. The COVID heart—One year after SARS-CoV-2 infection, patients have an array of increased cardiovascular risks. JAMA327(12), 1113–1114. 10.1001/jama.2022.2411 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35234824</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda, N. &amp; Manabe, I. Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling. Int. J. Inflamm.2011, 535241. 10.4061/2011/535241 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3175723</ArticleId><ArticleId IdType="pubmed">21941677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinnell, J., Turner, S. &amp; Howell, S. Cardiac muscle physiology. Contin. Educ. Anaesth. Crit. Care Pain7(3), 85–88. 10.1093/bjaceaccp/mkm013 (2007).</Citation></Reference><Reference><Citation>Ivey, M. J. &amp; Tallquist, M. D. Defining the cardiac fibroblast. Circ. J.80(11), 2269–2276. 10.1253/circj.CJ-16-1003 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588900</ArticleId><ArticleId IdType="pubmed">27746422</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarras, S., Beis, D., Nikouli, S., Tsikitis, M. &amp; Capetanaki, Y. Three in a box: Understanding cardiomyocyte, fibroblast, and innate immune cell interactions to orchestrate cardiac repair processes. Front. Cardiovasc. Med.10.3389/fcvm.2019.00032 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6454035</ArticleId><ArticleId IdType="pubmed">31001541</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis, N. G. The extracellular matrix in ischemic and nonischemic heart failure. Circ. Res.125(1), 117–146. 10.1161/circresaha.119.311148 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6588179</ArticleId><ArticleId IdType="pubmed">31219741</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna, A. &amp; Frangogiannis, N. G. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc. Drugs Ther.34(6), 849–863. 10.1007/s10557-020-07071-0 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479403</ArticleId><ArticleId IdType="pubmed">32902739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanjare, M. &amp; Huang, N. F. Regulation of the microenvironment for cardiac tissue engineering. Regen. Med.12(2), 187–201. 10.2217/rme-2016-0132 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348721</ArticleId><ArticleId IdType="pubmed">28244821</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, K., Li, Y. Y. &amp; Jin, J. A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Sig. Transduct. Target. Ther.6(1), 79. 10.1038/s41392-020-00455-6 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7897720</ArticleId><ArticleId IdType="pubmed">33612829</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy, A. S. et al. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection. Arch. Virol.166(12), 3301–3310. 10.1007/s00705-021-05247-z (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459145</ArticleId><ArticleId IdType="pubmed">34554303</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish, M. L., Franklin, R. A., Zhou, X. &amp; Medzhitov, R. Tissue homeostasis and inflammation. Annu. Rev. Immunol.39(1), 557–581. 10.1146/annurev-immunol-061020-053734 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33651964</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer, K. A. et al. Large-scale multi-omic analysis of COVID-19 severity. Cell Syst.12(1), 23-40.e7. 10.1016/j.cels.2020.10.003 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy, C. W. &amp; Fonarow, G. C. Coronavirus disease 2019 (COVID-19) and the heart—Is heart failure the next chapter?. JAMA Cardiol.5(11), 1216–1217. 10.1001/jamacardio.2020.3575 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32730614</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava S, Grizzle WE. Biomarkers and the genetics of early neoplastic lesions. (1875–8592 (Electronic)).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3478673</ArticleId><ArticleId IdType="pubmed">22112469</ArticleId></ArticleIdList></Reference><Reference><Citation>Casamassimi, A., Federico, A., Rienzo, M., Esposito, S. &amp; Ciccodicola, A. Transcriptome profiling in human diseases: New advances and perspectives. Int. J. Mol. Sci.10.3390/ijms18081652 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578042</ArticleId><ArticleId IdType="pubmed">28758927</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu D, Ma C, Zeng Z et al. Identification of hub genes and transcription factor regulatory network for heart failure using RNA-seq data and robust rank aggregation analysis. (2297–055X (Print)).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9649652</ArticleId><ArticleId IdType="pubmed">36386304</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough, E. &amp; Barrett, T. The gene expression omnibus database. Methods Mol. Biol. (Clifton, NJ).1418, 93–110. 10.1007/978-1-4939-3578-9_5 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944384</ArticleId><ArticleId IdType="pubmed">27008011</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgar, R., Domrachev, M. &amp; Lash, A. E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucl. Acids Res.30(1), 207–210. 10.1093/nar/30.1.207 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99122</ArticleId><ArticleId IdType="pubmed">11752295</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. et al. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets. BMC Genom.22(125), 1–13 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889713</ArticleId><ArticleId IdType="pubmed">33602138</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eeden, C., Khan, L., Osman, M. S. &amp; Cohen Tervaert, J. W. Natural killer cell dysfunction and its role in COVID-19. Int. J. Mol. Sci.10.3390/ijms21176351 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7503862</ArticleId><ArticleId IdType="pubmed">32883007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, A. et al. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 Infection. Cell Rep. Med.1(4), 100052. 10.1016/j.xcrm.2020.100052 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323681</ArticleId><ArticleId IdType="pubmed">32835305</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. &amp; Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acids Res.28(1), 27–30. 10.1093/nar/28.1.27 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102409</ArticleId><ArticleId IdType="pubmed">10592173</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner, M. et al. Gene ontology: Tool for the unification of biology. Gene Ontol. Consort. Nat. Genet.25(1), 25–29. 10.1038/75556 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, S. et al. Disease modeling and disease gene discovery in cardiomyopathies: A molecular study of induced pluripotent stem cell generated cardiomyocytes. Int. J. Mol. Sci.10.3390/ijms22073311 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8037452</ArticleId><ArticleId IdType="pubmed">33805011</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Yang L, Nilsson-Payant B et al. SARS-CoV-2 Infected Cardiomyocytes Recruit Monocytes by Secreting CCL2. Research square. 10.21203/rs.3.rs-94634/v1. (2020)</Citation></Reference><Reference><Citation>Perez-Bermejo, J. A. et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci. Transl. Med.10.1126/scitranslmed.abf7872 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8128284</ArticleId><ArticleId IdType="pubmed">33723017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, S., Zhou, Y., Chen, Y. &amp; Gu, J. fastp: An ultra-fast all-in-one FASTQ preprocessor. Bioinformatics34(17), i884–i890. 10.1093/bioinformatics/bty560 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6129281</ArticleId><ArticleId IdType="pubmed">30423086</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbandi, S., Hesse, U., Rees, D. J. &amp; Christoffels, A. A glance at quality score: Implication for de novo transcriptome reconstruction of Illumina reads. Front. Genet.10.3389/fgene.2014.00017 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3921913</ArticleId><ArticleId IdType="pubmed">24575122</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. &amp; Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods14(4), 417–419. 10.1038/nmeth.4197 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, M. D. &amp; Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol.11(3), R25. 10.1186/gb-2010-11-3-r25 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864565</ArticleId><ArticleId IdType="pubmed">20196867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryuchkova-Mostacci, N. &amp; Robinson-Rechavi, M. A benchmark of gene expression tissue-specificity metrics. Brief. Bioinform.18(2), 205–214. 10.1093/bib/bbw008 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444245</ArticleId><ArticleId IdType="pubmed">26891983</ArticleId></ArticleIdList></Reference><Reference><Citation>Hänzelmann, S., Castelo, R. &amp; Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform.10.1186/1471-2105-14-7 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G. Enrichplot: Visualization of functional enrichment result. R Packag. Vers.1, 24. 10.18129/B9.bioc.enrichplot (2024).</Citation></Reference><Reference><Citation>Love, M. I., Huber, W. &amp; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15(12), 550. 10.1186/s13059-014-0550-8 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolte, F. S. et al. Responding to the challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Perspectives from the association for molecular pathology infectious disease subdivision leadership. J. Mol. Diagn.22(8), 968–974. 10.1016/j.jmoldx.2020.06.003 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303040</ArticleId><ArticleId IdType="pubmed">32565306</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, Y. et al. Effects of enalapril on TLR2/NF-κB signaling pathway and inflammatory factors in rabbits with chronic heart failure. Evid. Based Complement Alternat Med.10.1155/2021/9594607 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294953</ArticleId><ArticleId IdType="pubmed">34335842</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, H. et al. NF-κB1 inhibits c-Myc protein degradation through suppression of FBW7 expression. Oncotarget5(2), 493–505. 10.18632/oncotarget.1643 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3964224</ArticleId><ArticleId IdType="pubmed">24457827</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride, K., Robitaille, L., Tremblay, S., Argentin, S. &amp; Nemer, M. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. Mol. Cell. Biol.13(1), 600–612. 10.1128/mcb.13.1.600-612.1993 (1993).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC358939</ArticleId><ArticleId IdType="pubmed">8417355</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H. et al. Targeting NF-κB pathway for the therapy of diseases: Mechanism and clinical study. Sig. Transduct. Target Ther.5, 209. 10.1038/s41392-020-00312-6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7506548</ArticleId><ArticleId IdType="pubmed">32958760</ArticleId></ArticleIdList></Reference><Reference><Citation>Segiet, O. A., Piecuch, A., Mielanczyk, L., Michalski, M. &amp; Nowalany-Kozielska, E. Role of interleukins in heart failure with reduced ejection fraction. Anatol. J. Cardiol.10.14744/AnatolJCardiol.2019.32748 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6955051</ArticleId><ArticleId IdType="pubmed">31789611</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung, F. L., Zhu, T. Y., Au-Yeung, K. K., Siow, Y. L. &amp; Karmin, O. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int.62(4), 1160–1170 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12234286</ArticleId></ArticleIdList></Reference><Reference><Citation>He, K. L. &amp; Ting, A. T. A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol. Cell Biol.22(17), 6034–6045. 10.1128/MCB.22.17.6034-6045.2002 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC133997</ArticleId><ArticleId IdType="pubmed">12167698</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. F., Chuang, H. C. &amp; Tan, T. H. Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability. Int. J. Mol. Sci.20(11), 2668. 10.3390/ijms20112668 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6600639</ArticleId><ArticleId IdType="pubmed">31151270</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, B. et al. Sirt1 improves heart failure through modulating the NF-κB p65/microRNA-155/BNDF signaling cascade. Aging (Albany NY)13(10), 14482–14498. 10.18632/aging.103640 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8202895</ArticleId><ArticleId IdType="pubmed">33206628</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzikovic, L., de Vries, C. J. M. &amp; de Waard, V. NR4A nuclear receptors in cardiac remodeling and neurohormonal regulation. Trends Cardiovasc. Med.29(8), 429–437. 10.1016/j.tcm.2018.11.015 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30553703</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, H., Wang, Q., Ma, L. &amp; Wu, Y. ITGAM: A pivotal regulator in macrophage dynamics and cardiac function during sepsis-induced cardiomyopathy. Cureus16(4), e59342. 10.7759/cureus.59342 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11070384</ArticleId><ArticleId IdType="pubmed">38711712</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>